Core Metabolic
Bromcresol Green Dye-Binding, Albumin. 510(k) K251157, from Truvian Health (San Diego, CA). Product code CIX, class 2.
As of Nov 17, 2026, K251157 is an FDA 510(k) held by Truvian Health, substantially equivalent on Jan 9, 2026 after 269 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Jan 9, 2026
- Review time: 269 days
- Recalls: 0
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe Core Metabolic panel is part of the TruWellness Panel™ and is intended for use on the TruVerus™. The Core Metabolic panel (part of the TruWellness Panel™) is an in vitro diagnostic device and intended to be used for the quantitative determination of Glucose (GLU), Total Protein (TP), and Albumin (ALB) in lithium-heparinized venous whole blood in clinical laboratory or point-of-care settings.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Medicon Hellas Albumin, Medicon Hellas Calcium, Medicon Hellas Creatinine, Medicon Hellas…K200898 · Medicon Hellas S.A · Sep 21, 2021
- Piccolo(Tm) Primary Health Panel Reagent RotorK950164 · Abaxis, Inc. · Apr 13, 1995
Other CIX Clearances
The newest 510(k)s for the same product code; see every CIX device- Albumin BCG2K203248 · Abbott Ireland Diagnostics Division · Nov 23, 2021
- Medicon Hellas Albumin, Medicon Hellas Calcium, Medicon Hellas Creatinine, Medicon Hellas…K200898 · Medicon Hellas S.A · Sep 21, 2021
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Apr 15, 2025
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1035
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files